Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.

Identifieur interne : 000060 ( Main/Exploration ); précédent : 000059; suivant : 000061

Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.

Auteurs : Fatemeh Azizian-Farsani [Iran] ; Navid Abedpoor [Iran] ; Mohammad Hasan Sheikhha [Iran] ; Ali Osmay Gure [Turquie] ; Mohammad Hossein Nasr-Esfahani [Iran] ; Kamran Ghaedi [Iran]

Source :

RBID : pubmed:33117687

Abstract

Receptor for advanced glycation end-products (RAGE) is a multiligand binding and single-pass transmembrane protein taken in diverse chronic inflammatory conditions. RAGE behaves as a pattern recognition receptor, which binds and is engaged in the cellular response to a variety of damage-associated molecular pattern molecules, as well as HMGB1, S100 proteins, and AGEs (advanced glycation end-products). The RAGE activation turns out to a formation of numerous intracellular signaling mechanisms, resulting in the progression and prolongation of colorectal carcinoma (CRC). The RAGE expression correlates well with the survival of colon cancer cells. RAGE is involved in the tumorigenesis, which increases and develops well in the stressed tumor microenvironment. In this review, we summarized downstream signaling cascade activated by the multiligand activation of RAGE, as well as RAGE ligands and their sources, clinical studies, and tumor markers related to RAGE particularly in the inflammatory tumor microenvironment in CRC. Furthermore, the role of RAGE signaling pathway in CRC patients with diabetic mellitus is investigated. RAGE has been reported to drive assorted signaling pathways, including activator protein 1, nuclear factor-κB, signal transducer and activator of transcription 3, SMAD family member 4 (Smad4), mitogen-activated protein kinases, mammalian target of rapamycin, phosphoinositide 3-kinases, reticular activating system, Wnt/β-catenin pathway, and Glycogen synthase kinase 3β, and even microRNAs.

DOI: 10.3389/fonc.2020.552283
PubMed: 33117687
PubMed Central: PMC7551201


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.</title>
<author>
<name sortKey="Azizian Farsani, Fatemeh" sort="Azizian Farsani, Fatemeh" uniqKey="Azizian Farsani F" first="Fatemeh" last="Azizian-Farsani">Fatemeh Azizian-Farsani</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd</wicri:regionArea>
<wicri:noRegion>Yazd</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Abedpoor, Navid" sort="Abedpoor, Navid" uniqKey="Abedpoor N" first="Navid" last="Abedpoor">Navid Abedpoor</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan</wicri:regionArea>
<wicri:noRegion>Isfahan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hasan Sheikhha, Mohammad" sort="Hasan Sheikhha, Mohammad" uniqKey="Hasan Sheikhha M" first="Mohammad" last="Hasan Sheikhha">Mohammad Hasan Sheikhha</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd</wicri:regionArea>
<wicri:noRegion>Yazd</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gure, Ali Osmay" sort="Gure, Ali Osmay" uniqKey="Gure A" first="Ali Osmay" last="Gure">Ali Osmay Gure</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular Biology and Genetics, Faculty of Science, Bilkent University, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Molecular Biology and Genetics, Faculty of Science, Bilkent University, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nasr Esfahani, Mohammad Hossein" sort="Nasr Esfahani, Mohammad Hossein" uniqKey="Nasr Esfahani M" first="Mohammad Hossein" last="Nasr-Esfahani">Mohammad Hossein Nasr-Esfahani</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan</wicri:regionArea>
<wicri:noRegion>Isfahan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ghaedi, Kamran" sort="Ghaedi, Kamran" uniqKey="Ghaedi K" first="Kamran" last="Ghaedi">Kamran Ghaedi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan</wicri:regionArea>
<wicri:noRegion>Isfahan</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Cellular and Molecular Biology, Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Division of Cellular and Molecular Biology, Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan</wicri:regionArea>
<wicri:noRegion>Isfahan</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33117687</idno>
<idno type="pmid">33117687</idno>
<idno type="doi">10.3389/fonc.2020.552283</idno>
<idno type="pmc">PMC7551201</idno>
<idno type="wicri:Area/Main/Corpus">000006</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000006</idno>
<idno type="wicri:Area/Main/Curation">000006</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000006</idno>
<idno type="wicri:Area/Main/Exploration">000006</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.</title>
<author>
<name sortKey="Azizian Farsani, Fatemeh" sort="Azizian Farsani, Fatemeh" uniqKey="Azizian Farsani F" first="Fatemeh" last="Azizian-Farsani">Fatemeh Azizian-Farsani</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd</wicri:regionArea>
<wicri:noRegion>Yazd</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Abedpoor, Navid" sort="Abedpoor, Navid" uniqKey="Abedpoor N" first="Navid" last="Abedpoor">Navid Abedpoor</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan</wicri:regionArea>
<wicri:noRegion>Isfahan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hasan Sheikhha, Mohammad" sort="Hasan Sheikhha, Mohammad" uniqKey="Hasan Sheikhha M" first="Mohammad" last="Hasan Sheikhha">Mohammad Hasan Sheikhha</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd</wicri:regionArea>
<wicri:noRegion>Yazd</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gure, Ali Osmay" sort="Gure, Ali Osmay" uniqKey="Gure A" first="Ali Osmay" last="Gure">Ali Osmay Gure</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular Biology and Genetics, Faculty of Science, Bilkent University, Ankara, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Molecular Biology and Genetics, Faculty of Science, Bilkent University, Ankara</wicri:regionArea>
<wicri:noRegion>Ankara</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nasr Esfahani, Mohammad Hossein" sort="Nasr Esfahani, Mohammad Hossein" uniqKey="Nasr Esfahani M" first="Mohammad Hossein" last="Nasr-Esfahani">Mohammad Hossein Nasr-Esfahani</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan</wicri:regionArea>
<wicri:noRegion>Isfahan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ghaedi, Kamran" sort="Ghaedi, Kamran" uniqKey="Ghaedi K" first="Kamran" last="Ghaedi">Kamran Ghaedi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan</wicri:regionArea>
<wicri:noRegion>Isfahan</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Cellular and Molecular Biology, Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Division of Cellular and Molecular Biology, Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan</wicri:regionArea>
<wicri:noRegion>Isfahan</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Frontiers in oncology</title>
<idno type="ISSN">2234-943X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Receptor for advanced glycation end-products (RAGE) is a multiligand binding and single-pass transmembrane protein taken in diverse chronic inflammatory conditions. RAGE behaves as a pattern recognition receptor, which binds and is engaged in the cellular response to a variety of damage-associated molecular pattern molecules, as well as HMGB1, S100 proteins, and AGEs (advanced glycation end-products). The RAGE activation turns out to a formation of numerous intracellular signaling mechanisms, resulting in the progression and prolongation of colorectal carcinoma (CRC). The RAGE expression correlates well with the survival of colon cancer cells. RAGE is involved in the tumorigenesis, which increases and develops well in the stressed tumor microenvironment. In this review, we summarized downstream signaling cascade activated by the multiligand activation of RAGE, as well as RAGE ligands and their sources, clinical studies, and tumor markers related to RAGE particularly in the inflammatory tumor microenvironment in CRC. Furthermore, the role of RAGE signaling pathway in CRC patients with diabetic mellitus is investigated. RAGE has been reported to drive assorted signaling pathways, including activator protein 1, nuclear factor-κB, signal transducer and activator of transcription 3, SMAD family member 4 (Smad4), mitogen-activated protein kinases, mammalian target of rapamycin, phosphoinositide 3-kinases, reticular activating system, Wnt/β-catenin pathway, and Glycogen synthase kinase 3β, and even microRNAs.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">33117687</PMID>
<DateRevised>
<Year>2020</Year>
<Month>10</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">2234-943X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>10</Volume>
<PubDate>
<Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in oncology</Title>
<ISOAbbreviation>Front Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.</ArticleTitle>
<Pagination>
<MedlinePgn>552283</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fonc.2020.552283</ELocationID>
<Abstract>
<AbstractText>Receptor for advanced glycation end-products (RAGE) is a multiligand binding and single-pass transmembrane protein taken in diverse chronic inflammatory conditions. RAGE behaves as a pattern recognition receptor, which binds and is engaged in the cellular response to a variety of damage-associated molecular pattern molecules, as well as HMGB1, S100 proteins, and AGEs (advanced glycation end-products). The RAGE activation turns out to a formation of numerous intracellular signaling mechanisms, resulting in the progression and prolongation of colorectal carcinoma (CRC). The RAGE expression correlates well with the survival of colon cancer cells. RAGE is involved in the tumorigenesis, which increases and develops well in the stressed tumor microenvironment. In this review, we summarized downstream signaling cascade activated by the multiligand activation of RAGE, as well as RAGE ligands and their sources, clinical studies, and tumor markers related to RAGE particularly in the inflammatory tumor microenvironment in CRC. Furthermore, the role of RAGE signaling pathway in CRC patients with diabetic mellitus is investigated. RAGE has been reported to drive assorted signaling pathways, including activator protein 1, nuclear factor-κB, signal transducer and activator of transcription 3, SMAD family member 4 (Smad4), mitogen-activated protein kinases, mammalian target of rapamycin, phosphoinositide 3-kinases, reticular activating system, Wnt/β-catenin pathway, and Glycogen synthase kinase 3β, and even microRNAs.</AbstractText>
<CopyrightInformation>Copyright © 2020 Azizian-Farsani, Abedpoor, Hasan Sheikhha, Gure, Nasr-Esfahani and Ghaedi.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Azizian-Farsani</LastName>
<ForeName>Fatemeh</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abedpoor</LastName>
<ForeName>Navid</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hasan Sheikhha</LastName>
<ForeName>Mohammad</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gure</LastName>
<ForeName>Ali Osmay</ForeName>
<Initials>AO</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biology and Genetics, Faculty of Science, Bilkent University, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nasr-Esfahani</LastName>
<ForeName>Mohammad Hossein</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghaedi</LastName>
<ForeName>Kamran</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, Academic Center for Education, Culture and Reasearch (ACECR), Isfahan, Iran.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Division of Cellular and Molecular Biology, Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>09</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Front Oncol</MedlineTA>
<NlmUniqueID>101568867</NlmUniqueID>
<ISSNLinking>2234-943X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AGEs</Keyword>
<Keyword MajorTopicYN="N">CRC</Keyword>
<Keyword MajorTopicYN="N">RAGE (receptor for advanced glycation end products)</Keyword>
<Keyword MajorTopicYN="N">advanced glycation end products</Keyword>
<Keyword MajorTopicYN="N">colorectal cancer</Keyword>
<Keyword MajorTopicYN="N">damage-associated molecular pattern molecules (DAMPs)</Keyword>
<Keyword MajorTopicYN="N">pattern recognition receptor (PRR)</Keyword>
<Keyword MajorTopicYN="N">tumourogenesis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>08</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>10</Month>
<Day>29</Day>
<Hour>5</Hour>
<Minute>53</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>10</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>10</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33117687</ArticleId>
<ArticleId IdType="doi">10.3389/fonc.2020.552283</ArticleId>
<ArticleId IdType="pmc">PMC7551201</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Vis Exp. 2012 Feb 01;(60):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22331082</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Surg Oncol. 2009 Feb;16(2):440-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19023628</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Inflam. 2013;2013:403460</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24102034</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Atherosclerosis. 2008 Jan;196(1):9-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17826783</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Epidemiol Genet. 2012;3(4):294-304</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23205181</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Oncol. 2019 Nov 27;9:1284</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31828035</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncol Rep. 2003 Mar-Apr;10(2):445-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12579287</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Ther. 2017 Sep;177:44-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28223234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Carcinogenesis. 2008 Oct;29(10):2035-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18689872</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Pharmacother. 2016 Dec;84:1496-1503</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27876336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2012 Apr 1;175(7):653-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22422922</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2008 Jan 1;68(1):329-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18172327</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Sci. 2019 Nov;110(11):3565-3572</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31520559</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Breast Cancer Res Treat. 2019 Feb;173(3):559-571</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30368741</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FASEB J. 2008 May;22(5):1572-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18089847</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24639052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1987 Nov 5-11;330(6143):80-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3313057</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Onco Targets Ther. 2019 Nov 27;12:10311-10321</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31819515</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2010 Feb;176(2):528-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20019188</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2007 Sep;171(3):947-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17640970</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Med. 2001 Nov;7(11):783-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11788793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res Bull. 1995;37(4):417-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7620916</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Oct 1;322(4):1111-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15336958</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biol Cell. 2011 Sep;22(18):3344-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21795396</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2013 May 15;132(10):2349-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23047645</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2017 Jan 21;18(1):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28117708</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem J. 2006 Jun 1;396(2):201-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16683912</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Leukoc Biol. 2007 Jan;81(1):28-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16943388</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Lett. 2011 Dec 26;313(1):91-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21945853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Oncol. 2009 Feb;34(2):425-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19148477</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Cancer Res. 2014 Mar 01;4(2):89-115</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24660101</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Medicina (Kaunas). 2020 Jan 21;56(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31972987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2018 Mar;41(3):570-576</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29208654</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Free Radic Biol Med. 2018 Feb 1;115:436-446</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29269310</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2006 Aug 8;114(6):597-605</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16894049</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2007 Oct 4;26(45):6560-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17486081</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2011 Mar 4;144(5):646-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21376230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Med. 2011;17(7-8):709-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21327297</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2008 Oct 1;181(7):4666-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18802069</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 1993 Mar 15;191(2):565-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8384844</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2013 Feb 28;32(9):1202-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22469986</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Chemother. 2015 Nov;21(11):761-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26346678</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2017 Dec 13;8:1774</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29326691</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Biosci (Landmark Ed). 2011 Jun 01;16:2756-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21622207</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncol Rep. 2018 Oct;40(4):2137-2146</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30066914</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2007 Oct 1;121(7):1433-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17565747</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Nanomedicine. 2016 Aug 23;10 Spec Iss:281-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27601894</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Genet. 2016 Apr;209(4):143-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26975699</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharmacol Sci. 2019 Apr;139(4):266-274</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30871870</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Structure. 2012 Apr 4;20(4):654-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22483112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2007 Sep 1;121(5):1072-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17487845</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Mol Med. 2013 Jan;13(1):24-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22834835</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Gastroenterol. 2011 Apr;106(4):674-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21407178</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Ther Targets. 2011 Feb;15(2):183-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21204727</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Geriatr Oncol. 2014 Jan;5(1):40-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24484717</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2001 Jun 22;276(25):22699-708</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11278647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Med (Berl). 2008 May;86(5):507-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18322670</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2000 May 18;405(6784):354-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10830965</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Carcinogenesis. 2005 Feb;26(2):293-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15539404</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1992 Jul 25;267(21):14987-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1321822</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1993 Sep 15;268(26):19726-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8366113</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2004 Jul 15;23(32):5487-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15122322</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Glycobiology. 2005 Jul;15(7):16R-28R</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15764591</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncol Rep. 2012 Jul;28(1):303-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22552710</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Leukoc Biol. 2009 Sep;86(3):505-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19477910</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Leukoc Biol. 2009 Sep;86(3):557-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19451397</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transl Res. 2017 Dec 15;9(12):5181-5196</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29312476</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2003 May 10;104(6):722-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12640679</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2014 May 30;5(10):3220-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24952599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Diabetes Res. 2018 Sep 9;2018:3274084</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30271790</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Vasc Pharmacol. 2008 Jan;6(1):44-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18220939</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thromb Haemost. 2000 Dec;84(6):1087-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11154118</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2001 Oct;108(7):949-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11581294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Tissue Res. 2016 Aug;365(2):357-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26979829</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cancer Res Ther. 2019;15(2):317-323</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30964104</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16461460</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tumour Biol. 2014 Jul;35(7):6195-206</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25051912</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Biosci. 2001 Oct 01;6:D1151-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11578972</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2010 Aug;177(2):586-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20581057</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Biochem. 1992 Jul 15;207(2):541-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1633809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastrointest Cancer. 2020 Jun;51(2):478-483</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31168777</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):412-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12750235</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2003 Mar 15;170(6):3233-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12626582</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Korean J Physiol Pharmacol. 2014 Feb;18(1):1-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24634591</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Soc Trans. 2003 Dec;31(Pt 6):1372-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14641066</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2019 Sep 18;10:2243</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31620141</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2014 Mar 28;343(6178):1249288</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24625929</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Apr 26;8(4):e62092</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23637971</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tumour Biol. 2014 Apr;35(4):3171-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24248547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2019 Nov 18;9(1):17007</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31740727</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gastroenterology. 2006 Nov;131(5):1486-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17101323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2015 Feb;125(2):539-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25562324</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncology. 2010;79(3-4):313-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21412018</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Med Chem. 2006;13(17):1971-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16842191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Jun 4;279(23):24498-504</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15047714</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Sci. 2000 Feb;113 ( Pt 4):611-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10652254</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antioxid Redox Signal. 2020 Feb 10;32(5):309-330</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31578870</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1992 Jul 25;267(21):14998-5004</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1378843</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Prev Res (Phila). 2020 Jul;13(7):601-610</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32169887</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genomics. 1994 Sep 15;23(2):408-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7835890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2011 Nov;121(11):4526-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21985787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Mol Med. 2002 Jan;8(1):10-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11796261</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1213-1234</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30334619</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2015 Aug 21;6(24):20672-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26009899</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Pharmacol. 2012 Aug;166(8):2212-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22352842</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gastroenterology. 2011 May;140(6):1838-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21530750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2008 Oct 3;283(40):27255-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18667420</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer Res. 2011 Feb;9(2):133-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21228116</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2005 Mar;166(3):751-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15743787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Intern Med. 2004 Mar;255(3):332-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14871457</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gut. 2017 Apr;66(4):683-691</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26818619</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2004 Jun 15;64(12):4257-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15205339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Immunol. 2014 May;26(5):269-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24355664</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3799-804</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17360433</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neoplasma. 2010;57(1):55-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19895173</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1855-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26404963</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circ Res. 2003 Dec 12;93(12):1159-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14670831</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anticancer Res. 2015 Oct;35(10):5391-400</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26408701</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Med. 2020 Apr;45(4):1059-1072</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32124957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Signal. 2013 Nov;25(11):2185-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23838007</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Med (Berl). 2009 Mar;87(3):235-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19189073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 2015 Aug 19;589(18):2388-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26193421</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Mol Med. 2007 Dec;7(8):777-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18331236</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Rev Food Sci Nutr. 2018 Apr 13;58(6):893-904</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27646710</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dig Dis Sci. 2012 Jan;57(1):48-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22057282</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Basic Clin Pharmacol Toxicol. 2011 Dec;109(6):423-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21733122</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Commun Signal. 2009 May 08;7:12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19426472</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 1996 Apr;21(4):134-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8701470</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Cell Res. 2013 Aug 1;319(13):2081-2090</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23693020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Oncol. 2018 Oct;53(4):1481-1492</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30066846</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Carcinog. 2019 Apr;58(4):500-510</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30456802</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Brain. 2018 Nov 14;11(1):68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30428894</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Asian Pac J Cancer Prev. 2019 Aug 01;20(8):2503-2514</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31450926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neoplasia. 2012 Dec;14(12):1260-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23308057</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Biol Ther. 2010 Nov 15;10(10):1056-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20890108</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastroenterol. 2012 Oct;47(10):1073-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22467055</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Cancer. 2007 Jul 16;97(2):267-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17579622</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1430-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21527578</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2007 Oct 15;121(8):1744-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17594690</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Biol Med (Maywood). 2003 Apr;228(4):396-405</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12671184</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2008 Feb;1783(2):297-311</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18060880</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lipids Health Dis. 2018 May 24;17(1):122</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29793481</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Onco Targets Ther. 2020 Mar 20;13:2385-2397</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32256089</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomolecules. 2019 Oct 22;9(10):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31652642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2017 May 16;8(38):64534-64550</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28969092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Drug Metab. 2019;20(1):65-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30207227</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cutan Pathol. 1998 Nov;25(10):521-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9870670</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transl Res. 2016 May 15;8(5):2169-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27347324</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2014 Oct;12(10):661-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25198138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Hypotheses. 2005;64(6):1208-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15823719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastrointest Surg. 2010 Nov;14(11):1680-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20824364</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Gastroenterol. 2011 Jan 7;17(1):69-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21218086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Epidemiol Genet. 2017 Apr 15;8(2):8-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28533893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Immunol. 2003 Apr;24(4):155-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12697438</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging Dis. 2014 Jun 01;5(3):212-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24900944</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncol Lett. 2020 Apr;19(4):3215-3222</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32218866</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gastroenterology. 2002 Nov;123(5):1478-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12404222</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 1988 Jun;8(6):2402-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3405210</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2004 Apr;50(4):1207-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15077303</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Sci (Lond). 2009 Apr;116(8):621-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19275767</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2007 Jul 6;317(5834):124-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17615359</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2008 Feb 18;205(2):275-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18208974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virchows Arch. 2005 Apr;446(4):411-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15789216</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1843-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24962837</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Immunol. 2017 Aug;32:43-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28982615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dis Colon Rectum. 2007 Aug;50(8):1230-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17587138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biomed Biotechnol. 2010;2010:917108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20145712</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2001 Mar 31;357(9261):1041</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11293617</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 2010 Sep 6;190(5):881-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20819940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biochem. 1982 Sep;92(3):835-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6815169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Prolif. 2009 Oct;42(5):701-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19614672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2000 Jan 7;100(1):57-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10647931</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2562-2576</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32166512</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Agric Food Chem. 2019 Jul 17;67(28):7821-7831</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31260293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutrients. 2010 Dec;2(12):1247-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22254007</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2015 Sep;1850(9):1898-904</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26028296</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Epidemiol. 2016 Jun;42:115-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27100837</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Aug 20;9(8):e104699</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25140518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastroenterol Hepatol. 2020 May;35(5):788-794</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31498489</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2014 Jan 1;74(1):330-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24197136</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 1994 Oct 1;54(19):5236-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7923146</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biochem Pharmacol Res. 2013 Mar;1(1):15-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23662248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Nutr. 2017 May;117(9):1244-1256</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28643618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gut. 2006 Feb;55(2):234-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16118352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncology. 2007;73(1-2):72-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18334852</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CA Cancer J Clin. 2020 May;70(3):145-164</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32133645</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Breast Cancer Res. 2014 Oct 14;16(5):454</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25311085</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Carcinogenesis. 2010 Sep;31(9):1541-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20622003</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Immunol. 1988 Jun;72(3):510-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3048809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2005 May 27;280(21):20833-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15788416</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4908-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21383199</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci Res. 2012 Jun;90(6):1136-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22344976</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Drug Deliv Rev. 2002 Dec 7;54(12):1615-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12453678</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Cancer. 2013 Feb;49(3):741-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23040637</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2006 Dec;8(12):1369-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17128264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2008 Nov;10(11):1349-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18820689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2013 Apr 11;14(4):7959-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23579957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Complement Altern Med. 2014 Oct 28;14:422</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25351676</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Treat Rev. 2014 Jul;40(6):760-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24650927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microsc Res Tech. 2003 Apr 15;60(6):569-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12645005</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2018 Sep 26;9(10):1004</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30258050</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetologia. 2003 May;46(5):595-607</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12764580</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Cancer. 2016 Mar 01;16:174</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26931562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):1065-1074</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28237576</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2009 May 15;284(20):13804-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19297317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2006 Mar 24;281(12):8242-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16407300</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biochem. 2010 Apr;337(1-2):251-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19876719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Metastasis Rev. 2012 Jun;31(1-2):163-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22109080</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Iran</li>
<li>Turquie</li>
</country>
</list>
<tree>
<country name="Iran">
<noRegion>
<name sortKey="Azizian Farsani, Fatemeh" sort="Azizian Farsani, Fatemeh" uniqKey="Azizian Farsani F" first="Fatemeh" last="Azizian-Farsani">Fatemeh Azizian-Farsani</name>
</noRegion>
<name sortKey="Abedpoor, Navid" sort="Abedpoor, Navid" uniqKey="Abedpoor N" first="Navid" last="Abedpoor">Navid Abedpoor</name>
<name sortKey="Ghaedi, Kamran" sort="Ghaedi, Kamran" uniqKey="Ghaedi K" first="Kamran" last="Ghaedi">Kamran Ghaedi</name>
<name sortKey="Ghaedi, Kamran" sort="Ghaedi, Kamran" uniqKey="Ghaedi K" first="Kamran" last="Ghaedi">Kamran Ghaedi</name>
<name sortKey="Hasan Sheikhha, Mohammad" sort="Hasan Sheikhha, Mohammad" uniqKey="Hasan Sheikhha M" first="Mohammad" last="Hasan Sheikhha">Mohammad Hasan Sheikhha</name>
<name sortKey="Nasr Esfahani, Mohammad Hossein" sort="Nasr Esfahani, Mohammad Hossein" uniqKey="Nasr Esfahani M" first="Mohammad Hossein" last="Nasr-Esfahani">Mohammad Hossein Nasr-Esfahani</name>
</country>
<country name="Turquie">
<noRegion>
<name sortKey="Gure, Ali Osmay" sort="Gure, Ali Osmay" uniqKey="Gure A" first="Ali Osmay" last="Gure">Ali Osmay Gure</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000060 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000060 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33117687
   |texte=   Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33117687" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020